Jose Rivas Rios

Pharmacodynamic Effects of Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease: Results of the SWAP-4 Study

L. Been, J. Moon, D. Angiolillo, 2018, Circulation.

Pharmacodynamic Effects of Vorapaxar in Patients With and Without Diabetes Mellitus

L. Been, V. Kairouz, D. Angiolillo, 2019, JACC. Basic to translational science.

Diabetes and antiplatelet therapy: from bench to bedside.

D. Angiolillo, F. Rollini, J. R. Rivas Rios, 2018, Cardiovascular diagnosis and therapy.

Role of genetic testing in patients undergoing percutaneous coronary intervention

J. Moon, D. Angiolillo, L. Cavallari, 2018, Expert review of clinical pharmacology.

Effects of Edoxaban on the Cellular and Protein Phase of Coagulation in Patients with Coronary Artery Disease on Dual Antiplatelet Therapy with Aspirin and Clopidogrel: Results of the EDOX-APT Study

L. Been, J. Moon, V. Kairouz, 2019, Thrombosis and Haemostasis.

Effects of the Peripheral Opioid Receptor Antagonist Methylnaltrexone on the PK and PD Profiles of Ticagrelor in Patients With Coronary Artery Disease Treated With Morphine.

L. Been, D. Angiolillo, F. Franchi, 2019, JACC. Cardiovascular interventions.

Effects of D-allulose on glucose tolerance and insulin response to a standard oral sucrose load: results of a prospective, randomized, crossover study

L. Been, M. Tokuda, D. Angiolillo, 2021, BMJ Open Diabetes Research & Care.

Role of genetic testing in patients undergoing percutaneous coronary intervention

J. Moon, D. Angiolillo, L. Cavallari, 2018, Expert review of clinical pharmacology.